Table 2.
Results for whole-mouth gingivitis efficacy endpoints at baseline and week 8
| Baseline mean (SD)* | Adjusted mean (SE) change from baseline† | Percent treatment difference relative to sonic‡ | 2-Sided P-value | |
|---|---|---|---|---|
| MGI score | ||||
| Sonic brush | 2.113 (0.087) | 0.269 (0.0184) | – | <0.001 |
| Novel O-R brush | 2.128 (0.116) | 0.437 (0.0184) | 62.5% | |
| GBI score | ||||
| Sonic brush | 0.226 (0.128) | 0.115 (0.0069) | – | <0.001 |
| Novel O-R brush | 0.246 (0.167) | 0.174 (0.0069) | 51.3% | |
| Number of bleeding sites | ||||
| Sonic brush | 32.2 (15.26) | 14.8 (0.78) | – | <0.001 |
| Novel O-R brush | 33.4 (17.67) | 23.6 (0.77) | 59.5% |
Baseline gingivitis measures did not differ significantly (P ≥ 0.497) between treatment groups.
Reductions versus baseline were statistically significant for all measures for both brushes (P < 0.001).
Percent treatment difference relative to sonic = 100 * (novel O-R – sonic)/sonic.